Premium
Quercetin reduced the formation of N ‐acetyl‐ p ‐benzoquinoneimine, a toxic metabolite of paracetamol in rats and isolated rat hepatocytes
Author(s) -
Pingili Ravindrababu,
Pawar A. Krishnamanjari,
Challa Siva Reddy
Publication year - 2019
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.6365
Subject(s) - quercetin , metabolite , pharmacology , chemistry , acetaminophen , cyp3a4 , microsome , cyp2e1 , flavonoid , cytochrome p450 , metabolism , biochemistry , medicine , enzyme , antioxidant
N ‐acetyl‐ p ‐benzoquinoneimine (NAPQI) is toxic metabolite of paracetamol formed primarily by cytochrome P4502E1 (CYP2E1) metabolic pathway when administered at therapeutic doses or overdose. The influence of quercetin (flavonoid) on the bioactivation of paracetamol to NAPQI was investigated using rat liver microsomes and rats in vivo. Paracetamol (80 mg/kg) was administered orally without or with silymarin (100 mg/kg), a known inhibitor of CYP2E1, CYP3A4 and quercetin (10 and 20 mg/kg) to rats for 15 consecutive days. Area under the plasma concentration–time curve (AUC 0‐∞ ) and the peakplasma concentration (C max ) of paracetamol were dose‐dependently increased with quercetin (10 and 20 mg/kg) compared to paracetamol control group ( p < 0.001). On the other hand, the AUC 0‐∞ and C max of NAPQI were decreased significantly with quercetin. The same results were observed with silymarin also. The elevated liver and kidney functional enzymes/compounds were significantly reduced by quercetin and silymarin compared to paracetamol control group. The formation of NAPQI was reduced in the incubation samples in presence of quercetin in experiment using isolated rat hepatocytes. The presentstudy results revealed that quercetin might be inhibited the CYP2E1‐mediated metabolism of paracetamol; thereby decreased the formation of NAPQI and protected the liver and kidney.